Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
1998-11-03
Walsh, Stephen
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 514 12, 514 13, 514 14, 514 15, 435 691, A61K 3804, C07K 704, C12N 1500
Patent
active
058308512
ABSTRACT:
Peptides of 10 to 40 or more amino acid residues in length and having the sequence X.sub.3 X.sub.4 X.sub.5 GPX.sub.6 TWX.sub.7 X.sub.8 (SEQ ID NO:252) where each amino acid is indicated by standard one letter abbreviation; X.sub.3 is C; X.sub.4 is R, H, L, or W; X.sub.5 is M, F, or I; X.sub.6 is independently selected from any one of the 20 genetically coded L-amino acids; X.sub.7 is D, E, I, L, or V; and X.sub.8 is C, which bind and activate the erythropoietin receptor (EPO-R) or otherwise act as an EPO agonist, and methods for their use.
REFERENCES:
patent: 4677195 (1987-06-01), Hewick
patent: 4703008 (1987-10-01), Lin
patent: 5106954 (1992-04-01), Fibi
patent: 5278065 (1994-01-01), D'Andrea
patent: 5322837 (1994-06-01), Hewick et al.
patent: 5369014 (1994-11-01), Brugnara et al.
patent: 5399551 (1995-03-01), Ise et al.
patent: 5482924 (1996-01-01), Royet et al.
Barker, Peter L., et al. (1992) "Cyclic RGD Peptide Analogues as Antiplatelet Antithrombotics", J. Med. Chem., 35:2040-2048.
Or, Yat Sun, et al. (1991) "Cysteine Alkylation in Unprotected Peptides: Synthesis of a Carbavasopressin Analogue by Intramolecular Cysteine Alkylation", J. Org. Chem. 56:3146-3149.
Sawyer, Stephen T., et al. (1987) "Binding and Receptor-mediated Endocytosis of Erythropoietin in Friend Virus-infected Erythroid Cells", The Journal of Biological Chemistry, 262(12):5554-5562.
Sasaki, Hiroshi, et al. (1987) "Carbohydrate Structure of Erythropoietin Expressed in Chinese Hamster Ovary Cells by a Human Erythorpoietin cDNA", The Journal of Biological Chemistry, 262(25):12059-12076.
Sawyer, Stephen, T., et al. (1987) "Identification of the receptor for erythropoietin by cross-linking to Friend virus-infected erythroid cells", Proc. Natl. Acad. Sci. USA, 84:3690-3694.
Landschulz, Katherine T., et al. (1989) "Erythropoietin Receptors on Murine Erythroid Colony-Forming Units: Natural History", Blood, 73(6):1476-1486.
Kitamura, Toshio, et al. (1989) "Identification and Analysis of Human Erythropoietin Receptors on a Factor-Dependent Cell Line, TF-1", Blood, 73(2):375-380.
Krystal, Gerald (1983) "A Simple Microassay for Erythropoietin Based on .sup.3 H-Thymidine Incorporation into Spleen Cells from Phenylhydrazine Treated Mice", Exp. Hematol., 11(7):649-660.
Cwirla, Steven E., et al. (1990) "Peptides on phage: A vast library of peptides for identifying ligands", Proc. Natl. Acad. Sci. USA, 87:6378-6382.
Bowie, James U., et al. (1990) "Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions", Science, 247:1306-1310.
Chang Ray S.
Dower William J.
Kashyap Arun K.
Wrighton Nicholas C.
Affymax Technologies N.V.
Garrett-Wackowski Eugenia
Kemmerer Elizabeth C.
Stevens Lauren L.
Walsh Stephen
LandOfFree
Methods of administering peptides that bind to the erythropoieti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of administering peptides that bind to the erythropoieti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of administering peptides that bind to the erythropoieti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-689102